Company · CIK 1779578
BGM Group Ltd.
| CIK | 1779578 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | E9 |
| Listed | BGM (Nasdaq) |
| First annual or quarterly report | 2021-02-11 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-285635 | 2025-03-07 | 2025-04-02 | 2 | |
| 333-282998 | 2024-11-05 | 2024-11-22 | 2 | |
| 333-278591 | 2024-04-10 | 2024-05-16 | 2 | |
| 333-234460 | 2019-11-04 | 2021-01-12 | 12 |
Filings
19| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-04-02 | EFFECTDeclared effective | 333-285635 | 9999999995-25-000948 |
| 2025-03-07 | F-3Shelf registered | 333-285635 | 0001104659-25-021640 |
| 2024-11-22 | EFFECTDeclared effective | 333-282998 | 9999999995-24-003557 |
| 2024-11-05 | F-3Shelf registered | 333-282998 | 0001104659-24-114303 |
| 2024-05-16 | EFFECTDeclared effective | 333-278591 | 9999999995-24-001551 |
| 2024-04-10 | F-3Shelf registered | 333-278591 | 0001104659-24-045306 |
| 2021-01-12 | 424B4Final prospectus | 333-234460 | 0001104659-21-003514 |
| 2020-12-30 | EFFECTDeclared effective | 333-234460 | 9999999995-20-003695 |
| 2020-12-23 | F-1/AAmendment | 333-234460 | 0001104659-20-139040 |
| 2020-12-18 | F-1/AAmendment | 333-234460 | 0001104659-20-137181 |
| 2020-12-10 | F-1/AAmendment | 333-234460 | 0001104659-20-134149 |
| 2020-11-23 | F-1/AAmendment | 333-234460 | 0001104659-20-128343 |
| 2020-08-21 | F-1/AAmendment | 333-234460 | 0001104659-20-097495 |
| 2020-06-12 | F-1/AAmendment | 333-234460 | 0001104659-20-072836 |
| 2020-04-08 | F-1/AAmendment | 333-234460 | 0001104659-20-044672 |
| 2020-01-02 | F-1/AAmendment | 333-234460 | 0001104659-20-000419 |
| 2019-11-27 | F-1/AAmendment | 333-234460 | 0001104659-19-068338 |
| 2019-11-04 | F-1Registration filed | 333-234460 | 0001104659-19-059119 |
| 2019-06-17 | DRSDraft made public | 377-02698 | 0001144204-19-031058 |